Global Therapeutic Antibody Discovery Services Supply, Demand and Key Producers, 2026-2032
The global Therapeutic Antibody Discovery Services market size is expected to reach $ 4222 million by 2032, rising at a market growth of 11.4% CAGR during the forecast period (2026-2032).
Therapeutic antibody discovery services refer to providing pharmaceutical companies with integrated R&D services, from antigen design, antibody screening, affinity optimization to candidate antibody acquisition, based on antibody screening and engineering platforms (such as hybridoma, phage display, single B cell technology, etc.), for the development of monoclonal or polyclonal antibody drugs with therapeutic potential.
The industry trend for therapeutic antibody discovery services is experiencing significant growth due to the increasing demand for antibody-based therapeutics. The advancements in biotechnology and computational biology have accelerated the discovery and development of antibodies, leading to more targeted and effective therapeutic strategies. With the expanding understanding of disease mechanisms and the constant need for new treatment options, therapeutic antibody discovery services are crucial for identifying and developing innovative and targeted antibody-based therapeutics. Furthermore, the trend towards personalized and precision medicine has fueled the demand for therapeutic antibody discovery services, as they enable the development of targeted treatments tailored to individual patients' needs. Overall, the future of therapeutic antibody discovery services looks bright as they continue to play a vital role in the development of novel and effective antibody-based therapeutics.
This report studies the global Therapeutic Antibody Discovery Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Therapeutic Antibody Discovery Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Antibody Discovery Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Therapeutic Antibody Discovery Services total market, 2021-2032, (USD Million)
Global Therapeutic Antibody Discovery Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Therapeutic Antibody Discovery Services total market, key domestic companies, and share, (USD Million)
Global Therapeutic Antibody Discovery Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Therapeutic Antibody Discovery Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Therapeutic Antibody Discovery Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Therapeutic Antibody Discovery Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocytogen, Charles River Laboratories, Abcam, Alloy Therapeutics, Creative Biolabs, Twist Bioscience, Rapid Novor, Curia, AlivaMab Biologics, Integrated DNA Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Therapeutic Antibody Discovery Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Therapeutic Antibody Discovery Services Market, By Region:
1. How big is the global Therapeutic Antibody Discovery Services market?
2. What is the demand of the global Therapeutic Antibody Discovery Services market?
3. What is the year over year growth of the global Therapeutic Antibody Discovery Services market?
4. What is the total value of the global Therapeutic Antibody Discovery Services market?
5. Who are the Major Players in the global Therapeutic Antibody Discovery Services market?
6. What are the growth factors driving the market demand?
Therapeutic antibody discovery services refer to providing pharmaceutical companies with integrated R&D services, from antigen design, antibody screening, affinity optimization to candidate antibody acquisition, based on antibody screening and engineering platforms (such as hybridoma, phage display, single B cell technology, etc.), for the development of monoclonal or polyclonal antibody drugs with therapeutic potential.
The industry trend for therapeutic antibody discovery services is experiencing significant growth due to the increasing demand for antibody-based therapeutics. The advancements in biotechnology and computational biology have accelerated the discovery and development of antibodies, leading to more targeted and effective therapeutic strategies. With the expanding understanding of disease mechanisms and the constant need for new treatment options, therapeutic antibody discovery services are crucial for identifying and developing innovative and targeted antibody-based therapeutics. Furthermore, the trend towards personalized and precision medicine has fueled the demand for therapeutic antibody discovery services, as they enable the development of targeted treatments tailored to individual patients' needs. Overall, the future of therapeutic antibody discovery services looks bright as they continue to play a vital role in the development of novel and effective antibody-based therapeutics.
This report studies the global Therapeutic Antibody Discovery Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Therapeutic Antibody Discovery Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Antibody Discovery Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Therapeutic Antibody Discovery Services total market, 2021-2032, (USD Million)
Global Therapeutic Antibody Discovery Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Therapeutic Antibody Discovery Services total market, key domestic companies, and share, (USD Million)
Global Therapeutic Antibody Discovery Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Therapeutic Antibody Discovery Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Therapeutic Antibody Discovery Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Therapeutic Antibody Discovery Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocytogen, Charles River Laboratories, Abcam, Alloy Therapeutics, Creative Biolabs, Twist Bioscience, Rapid Novor, Curia, AlivaMab Biologics, Integrated DNA Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Therapeutic Antibody Discovery Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Therapeutic Antibody Discovery Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Discovery of CAR-T Antibody Drugs
- Discovery of Monoclonal Antibody Drugs
- Discovery of ADC Antibody Drugs
- Others
- Mouse Antibodies
- Chimeric Antibodies
- Humanized Antibodies
- Fully Human Antibodies
- Soluble Protein Targets
- Membrane Protein Targets
- GPCR Targets
- Ion Channel Targets
- Cell Surface Antigen Targets
- Biotechnology
- Medical
- University
- Others
- Biocytogen
- Charles River Laboratories
- Abcam
- Alloy Therapeutics
- Creative Biolabs
- Twist Bioscience
- Rapid Novor
- Curia
- AlivaMab Biologics
- Integrated DNA Technologies
- Antibody Solutions
- Eurofins Discovery
- GenScript
- Evotec
- Aurigene Pharmaceutical Services
- Yumab
- Creative Bioarray
- CD ComputaBio
- Biomolecular Discovery Services
- ProteoGenix
- Sichuan NB Biolab
- Viva Biotech
- SAFE Pharmaceutical Technology
- Shanghai Medicilon
- WuXi Biologics
- XtalPi
- Detaibio
- Cusabio
1. How big is the global Therapeutic Antibody Discovery Services market?
2. What is the demand of the global Therapeutic Antibody Discovery Services market?
3. What is the year over year growth of the global Therapeutic Antibody Discovery Services market?
4. What is the total value of the global Therapeutic Antibody Discovery Services market?
5. Who are the Major Players in the global Therapeutic Antibody Discovery Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Therapeutic Antibody Discovery Services Introduction
1.2 World Therapeutic Antibody Discovery Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Therapeutic Antibody Discovery Services Total Market by Region (by Headquarter Location)
1.3.1 World Therapeutic Antibody Discovery Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.3 China Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.4 Europe Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.5 Japan Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.6 South Korea Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.8 India Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Antibody Discovery Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.2 World Therapeutic Antibody Discovery Services Consumption Value by Region
2.2.1 World Therapeutic Antibody Discovery Services Consumption Value by Region (2021-2026)
2.2.2 World Therapeutic Antibody Discovery Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.4 China Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.5 Europe Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.6 Japan Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.7 South Korea Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.8 ASEAN Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.9 India Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
3 WORLD THERAPEUTIC ANTIBODY DISCOVERY SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Therapeutic Antibody Discovery Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Therapeutic Antibody Discovery Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Therapeutic Antibody Discovery Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Therapeutic Antibody Discovery Services in 2025
3.3 Therapeutic Antibody Discovery Services Company Evaluation Quadrant
3.4 Therapeutic Antibody Discovery Services Market: Overall Company Footprint Analysis
3.4.1 Therapeutic Antibody Discovery Services Market: Region Footprint
3.4.2 Therapeutic Antibody Discovery Services Market: Company Product Type Footprint
3.4.3 Therapeutic Antibody Discovery Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Therapeutic Antibody Discovery Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Therapeutic Antibody Discovery Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Therapeutic Antibody Discovery Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Therapeutic Antibody Discovery Services Consumption Value Comparison
4.2.1 United States VS China: Therapeutic Antibody Discovery Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Therapeutic Antibody Discovery Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Therapeutic Antibody Discovery Services Companies and Market Share, 2021-2026
4.3.1 United States Based Therapeutic Antibody Discovery Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026)
4.4 China Based Companies Therapeutic Antibody Discovery Services Revenue and Market Share, 2021-2026
4.4.1 China Based Therapeutic Antibody Discovery Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026)
4.5 Rest of World Based Therapeutic Antibody Discovery Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Therapeutic Antibody Discovery Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Therapeutic Antibody Discovery Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Therapeutic Antibody Discovery Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Discovery of CAR-T Antibody Drugs
5.2.2 Discovery of Monoclonal Antibody Drugs
5.2.3 Discovery of ADC Antibody Drugs
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
5.3.2 World Therapeutic Antibody Discovery Services Market Size by Type (2027-2032)
5.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ANTIBODY SOURCES
6.1 World Therapeutic Antibody Discovery Services Market Size Overview by Antibody Sources: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Antibody Sources
6.2.1 Mouse Antibodies
6.2.2 Chimeric Antibodies
6.2.3 Humanized Antibodies
6.2.4 Fully Human Antibodies
6.3 Market Segment by Antibody Sources
6.3.1 World Therapeutic Antibody Discovery Services Market Size by Antibody Sources (2021-2026)
6.3.2 World Therapeutic Antibody Discovery Services Market Size by Antibody Sources (2027-2032)
6.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Antibody Sources (2027-2032)
7 MARKET ANALYSIS BY TARGET TYPES
7.1 World Therapeutic Antibody Discovery Services Market Size Overview by Target Types: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Target Types
7.2.1 Soluble Protein Targets
7.2.2 Membrane Protein Targets
7.2.3 GPCR Targets
7.2.4 Ion Channel Targets
7.2.5 Cell Surface Antigen Targets
7.3 Market Segment by Target Types
7.3.1 World Therapeutic Antibody Discovery Services Market Size by Target Types (2021-2026)
7.3.2 World Therapeutic Antibody Discovery Services Market Size by Target Types (2027-2032)
7.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Target Types (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Therapeutic Antibody Discovery Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biotechnology
8.2.2 Medical
8.2.3 University
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
8.3.2 World Therapeutic Antibody Discovery Services Market Size by Application (2027-2032)
8.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Biocytogen
9.1.1 Biocytogen Details
9.1.2 Biocytogen Major Business
9.1.3 Biocytogen Therapeutic Antibody Discovery Services Product and Services
9.1.4 Biocytogen Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Biocytogen Recent Developments/Updates
9.1.6 Biocytogen Competitive Strengths & Weaknesses
9.2 Charles River Laboratories
9.2.1 Charles River Laboratories Details
9.2.2 Charles River Laboratories Major Business
9.2.3 Charles River Laboratories Therapeutic Antibody Discovery Services Product and Services
9.2.4 Charles River Laboratories Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Charles River Laboratories Recent Developments/Updates
9.2.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.3 Abcam
9.3.1 Abcam Details
9.3.2 Abcam Major Business
9.3.3 Abcam Therapeutic Antibody Discovery Services Product and Services
9.3.4 Abcam Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abcam Recent Developments/Updates
9.3.6 Abcam Competitive Strengths & Weaknesses
9.4 Alloy Therapeutics
9.4.1 Alloy Therapeutics Details
9.4.2 Alloy Therapeutics Major Business
9.4.3 Alloy Therapeutics Therapeutic Antibody Discovery Services Product and Services
9.4.4 Alloy Therapeutics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Alloy Therapeutics Recent Developments/Updates
9.4.6 Alloy Therapeutics Competitive Strengths & Weaknesses
9.5 Creative Biolabs
9.5.1 Creative Biolabs Details
9.5.2 Creative Biolabs Major Business
9.5.3 Creative Biolabs Therapeutic Antibody Discovery Services Product and Services
9.5.4 Creative Biolabs Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Creative Biolabs Recent Developments/Updates
9.5.6 Creative Biolabs Competitive Strengths & Weaknesses
9.6 Twist Bioscience
9.6.1 Twist Bioscience Details
9.6.2 Twist Bioscience Major Business
9.6.3 Twist Bioscience Therapeutic Antibody Discovery Services Product and Services
9.6.4 Twist Bioscience Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Twist Bioscience Recent Developments/Updates
9.6.6 Twist Bioscience Competitive Strengths & Weaknesses
9.7 Rapid Novor
9.7.1 Rapid Novor Details
9.7.2 Rapid Novor Major Business
9.7.3 Rapid Novor Therapeutic Antibody Discovery Services Product and Services
9.7.4 Rapid Novor Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Rapid Novor Recent Developments/Updates
9.7.6 Rapid Novor Competitive Strengths & Weaknesses
9.8 Curia
9.8.1 Curia Details
9.8.2 Curia Major Business
9.8.3 Curia Therapeutic Antibody Discovery Services Product and Services
9.8.4 Curia Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Curia Recent Developments/Updates
9.8.6 Curia Competitive Strengths & Weaknesses
9.9 AlivaMab Biologics
9.9.1 AlivaMab Biologics Details
9.9.2 AlivaMab Biologics Major Business
9.9.3 AlivaMab Biologics Therapeutic Antibody Discovery Services Product and Services
9.9.4 AlivaMab Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 AlivaMab Biologics Recent Developments/Updates
9.9.6 AlivaMab Biologics Competitive Strengths & Weaknesses
9.10 Integrated DNA Technologies
9.10.1 Integrated DNA Technologies Details
9.10.2 Integrated DNA Technologies Major Business
9.10.3 Integrated DNA Technologies Therapeutic Antibody Discovery Services Product and Services
9.10.4 Integrated DNA Technologies Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Integrated DNA Technologies Recent Developments/Updates
9.10.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
9.11 Antibody Solutions
9.11.1 Antibody Solutions Details
9.11.2 Antibody Solutions Major Business
9.11.3 Antibody Solutions Therapeutic Antibody Discovery Services Product and Services
9.11.4 Antibody Solutions Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Antibody Solutions Recent Developments/Updates
9.11.6 Antibody Solutions Competitive Strengths & Weaknesses
9.12 Eurofins Discovery
9.12.1 Eurofins Discovery Details
9.12.2 Eurofins Discovery Major Business
9.12.3 Eurofins Discovery Therapeutic Antibody Discovery Services Product and Services
9.12.4 Eurofins Discovery Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Eurofins Discovery Recent Developments/Updates
9.12.6 Eurofins Discovery Competitive Strengths & Weaknesses
9.13 GenScript
9.13.1 GenScript Details
9.13.2 GenScript Major Business
9.13.3 GenScript Therapeutic Antibody Discovery Services Product and Services
9.13.4 GenScript Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 GenScript Recent Developments/Updates
9.13.6 GenScript Competitive Strengths & Weaknesses
9.14 Evotec
9.14.1 Evotec Details
9.14.2 Evotec Major Business
9.14.3 Evotec Therapeutic Antibody Discovery Services Product and Services
9.14.4 Evotec Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Evotec Recent Developments/Updates
9.14.6 Evotec Competitive Strengths & Weaknesses
9.15 Aurigene Pharmaceutical Services
9.15.1 Aurigene Pharmaceutical Services Details
9.15.2 Aurigene Pharmaceutical Services Major Business
9.15.3 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Product and Services
9.15.4 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Aurigene Pharmaceutical Services Recent Developments/Updates
9.15.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
9.16 Yumab
9.16.1 Yumab Details
9.16.2 Yumab Major Business
9.16.3 Yumab Therapeutic Antibody Discovery Services Product and Services
9.16.4 Yumab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Yumab Recent Developments/Updates
9.16.6 Yumab Competitive Strengths & Weaknesses
9.17 Creative Bioarray
9.17.1 Creative Bioarray Details
9.17.2 Creative Bioarray Major Business
9.17.3 Creative Bioarray Therapeutic Antibody Discovery Services Product and Services
9.17.4 Creative Bioarray Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Creative Bioarray Recent Developments/Updates
9.17.6 Creative Bioarray Competitive Strengths & Weaknesses
9.18 CD ComputaBio
9.18.1 CD ComputaBio Details
9.18.2 CD ComputaBio Major Business
9.18.3 CD ComputaBio Therapeutic Antibody Discovery Services Product and Services
9.18.4 CD ComputaBio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 CD ComputaBio Recent Developments/Updates
9.18.6 CD ComputaBio Competitive Strengths & Weaknesses
9.19 Biomolecular Discovery Services
9.19.1 Biomolecular Discovery Services Details
9.19.2 Biomolecular Discovery Services Major Business
9.19.3 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Product and Services
9.19.4 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Biomolecular Discovery Services Recent Developments/Updates
9.19.6 Biomolecular Discovery Services Competitive Strengths & Weaknesses
9.20 ProteoGenix
9.20.1 ProteoGenix Details
9.20.2 ProteoGenix Major Business
9.20.3 ProteoGenix Therapeutic Antibody Discovery Services Product and Services
9.20.4 ProteoGenix Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 ProteoGenix Recent Developments/Updates
9.20.6 ProteoGenix Competitive Strengths & Weaknesses
9.21 Sichuan NB Biolab
9.21.1 Sichuan NB Biolab Details
9.21.2 Sichuan NB Biolab Major Business
9.21.3 Sichuan NB Biolab Therapeutic Antibody Discovery Services Product and Services
9.21.4 Sichuan NB Biolab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Sichuan NB Biolab Recent Developments/Updates
9.21.6 Sichuan NB Biolab Competitive Strengths & Weaknesses
9.22 Viva Biotech
9.22.1 Viva Biotech Details
9.22.2 Viva Biotech Major Business
9.22.3 Viva Biotech Therapeutic Antibody Discovery Services Product and Services
9.22.4 Viva Biotech Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Viva Biotech Recent Developments/Updates
9.22.6 Viva Biotech Competitive Strengths & Weaknesses
9.23 SAFE Pharmaceutical Technology
9.23.1 SAFE Pharmaceutical Technology Details
9.23.2 SAFE Pharmaceutical Technology Major Business
9.23.3 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Product and Services
9.23.4 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 SAFE Pharmaceutical Technology Recent Developments/Updates
9.23.6 SAFE Pharmaceutical Technology Competitive Strengths & Weaknesses
9.24 Shanghai Medicilon
9.24.1 Shanghai Medicilon Details
9.24.2 Shanghai Medicilon Major Business
9.24.3 Shanghai Medicilon Therapeutic Antibody Discovery Services Product and Services
9.24.4 Shanghai Medicilon Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Shanghai Medicilon Recent Developments/Updates
9.24.6 Shanghai Medicilon Competitive Strengths & Weaknesses
9.25 WuXi Biologics
9.25.1 WuXi Biologics Details
9.25.2 WuXi Biologics Major Business
9.25.3 WuXi Biologics Therapeutic Antibody Discovery Services Product and Services
9.25.4 WuXi Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 WuXi Biologics Recent Developments/Updates
9.25.6 WuXi Biologics Competitive Strengths & Weaknesses
9.26 XtalPi
9.26.1 XtalPi Details
9.26.2 XtalPi Major Business
9.26.3 XtalPi Therapeutic Antibody Discovery Services Product and Services
9.26.4 XtalPi Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 XtalPi Recent Developments/Updates
9.26.6 XtalPi Competitive Strengths & Weaknesses
9.27 Detaibio
9.27.1 Detaibio Details
9.27.2 Detaibio Major Business
9.27.3 Detaibio Therapeutic Antibody Discovery Services Product and Services
9.27.4 Detaibio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Detaibio Recent Developments/Updates
9.27.6 Detaibio Competitive Strengths & Weaknesses
9.28 Cusabio
9.28.1 Cusabio Details
9.28.2 Cusabio Major Business
9.28.3 Cusabio Therapeutic Antibody Discovery Services Product and Services
9.28.4 Cusabio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Cusabio Recent Developments/Updates
9.28.6 Cusabio Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Therapeutic Antibody Discovery Services Industry Chain
10.2 Therapeutic Antibody Discovery Services Upstream Analysis
10.3 Therapeutic Antibody Discovery Services Midstream Analysis
10.4 Therapeutic Antibody Discovery Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Therapeutic Antibody Discovery Services Introduction
1.2 World Therapeutic Antibody Discovery Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Therapeutic Antibody Discovery Services Total Market by Region (by Headquarter Location)
1.3.1 World Therapeutic Antibody Discovery Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.3 China Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.4 Europe Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.5 Japan Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.6 South Korea Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.3.8 India Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Antibody Discovery Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.2 World Therapeutic Antibody Discovery Services Consumption Value by Region
2.2.1 World Therapeutic Antibody Discovery Services Consumption Value by Region (2021-2026)
2.2.2 World Therapeutic Antibody Discovery Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.4 China Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.5 Europe Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.6 Japan Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.7 South Korea Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.8 ASEAN Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
2.9 India Therapeutic Antibody Discovery Services Consumption Value (2021-2032)
3 WORLD THERAPEUTIC ANTIBODY DISCOVERY SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Therapeutic Antibody Discovery Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Therapeutic Antibody Discovery Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Therapeutic Antibody Discovery Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Therapeutic Antibody Discovery Services in 2025
3.3 Therapeutic Antibody Discovery Services Company Evaluation Quadrant
3.4 Therapeutic Antibody Discovery Services Market: Overall Company Footprint Analysis
3.4.1 Therapeutic Antibody Discovery Services Market: Region Footprint
3.4.2 Therapeutic Antibody Discovery Services Market: Company Product Type Footprint
3.4.3 Therapeutic Antibody Discovery Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Therapeutic Antibody Discovery Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Therapeutic Antibody Discovery Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Therapeutic Antibody Discovery Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Therapeutic Antibody Discovery Services Consumption Value Comparison
4.2.1 United States VS China: Therapeutic Antibody Discovery Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Therapeutic Antibody Discovery Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Therapeutic Antibody Discovery Services Companies and Market Share, 2021-2026
4.3.1 United States Based Therapeutic Antibody Discovery Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026)
4.4 China Based Companies Therapeutic Antibody Discovery Services Revenue and Market Share, 2021-2026
4.4.1 China Based Therapeutic Antibody Discovery Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026)
4.5 Rest of World Based Therapeutic Antibody Discovery Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Therapeutic Antibody Discovery Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Therapeutic Antibody Discovery Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Therapeutic Antibody Discovery Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Discovery of CAR-T Antibody Drugs
5.2.2 Discovery of Monoclonal Antibody Drugs
5.2.3 Discovery of ADC Antibody Drugs
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Therapeutic Antibody Discovery Services Market Size by Type (2021-2026)
5.3.2 World Therapeutic Antibody Discovery Services Market Size by Type (2027-2032)
5.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY ANTIBODY SOURCES
6.1 World Therapeutic Antibody Discovery Services Market Size Overview by Antibody Sources: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Antibody Sources
6.2.1 Mouse Antibodies
6.2.2 Chimeric Antibodies
6.2.3 Humanized Antibodies
6.2.4 Fully Human Antibodies
6.3 Market Segment by Antibody Sources
6.3.1 World Therapeutic Antibody Discovery Services Market Size by Antibody Sources (2021-2026)
6.3.2 World Therapeutic Antibody Discovery Services Market Size by Antibody Sources (2027-2032)
6.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Antibody Sources (2027-2032)
7 MARKET ANALYSIS BY TARGET TYPES
7.1 World Therapeutic Antibody Discovery Services Market Size Overview by Target Types: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Target Types
7.2.1 Soluble Protein Targets
7.2.2 Membrane Protein Targets
7.2.3 GPCR Targets
7.2.4 Ion Channel Targets
7.2.5 Cell Surface Antigen Targets
7.3 Market Segment by Target Types
7.3.1 World Therapeutic Antibody Discovery Services Market Size by Target Types (2021-2026)
7.3.2 World Therapeutic Antibody Discovery Services Market Size by Target Types (2027-2032)
7.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Target Types (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Therapeutic Antibody Discovery Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biotechnology
8.2.2 Medical
8.2.3 University
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Therapeutic Antibody Discovery Services Market Size by Application (2021-2026)
8.3.2 World Therapeutic Antibody Discovery Services Market Size by Application (2027-2032)
8.3.3 World Therapeutic Antibody Discovery Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Biocytogen
9.1.1 Biocytogen Details
9.1.2 Biocytogen Major Business
9.1.3 Biocytogen Therapeutic Antibody Discovery Services Product and Services
9.1.4 Biocytogen Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Biocytogen Recent Developments/Updates
9.1.6 Biocytogen Competitive Strengths & Weaknesses
9.2 Charles River Laboratories
9.2.1 Charles River Laboratories Details
9.2.2 Charles River Laboratories Major Business
9.2.3 Charles River Laboratories Therapeutic Antibody Discovery Services Product and Services
9.2.4 Charles River Laboratories Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Charles River Laboratories Recent Developments/Updates
9.2.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.3 Abcam
9.3.1 Abcam Details
9.3.2 Abcam Major Business
9.3.3 Abcam Therapeutic Antibody Discovery Services Product and Services
9.3.4 Abcam Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abcam Recent Developments/Updates
9.3.6 Abcam Competitive Strengths & Weaknesses
9.4 Alloy Therapeutics
9.4.1 Alloy Therapeutics Details
9.4.2 Alloy Therapeutics Major Business
9.4.3 Alloy Therapeutics Therapeutic Antibody Discovery Services Product and Services
9.4.4 Alloy Therapeutics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Alloy Therapeutics Recent Developments/Updates
9.4.6 Alloy Therapeutics Competitive Strengths & Weaknesses
9.5 Creative Biolabs
9.5.1 Creative Biolabs Details
9.5.2 Creative Biolabs Major Business
9.5.3 Creative Biolabs Therapeutic Antibody Discovery Services Product and Services
9.5.4 Creative Biolabs Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Creative Biolabs Recent Developments/Updates
9.5.6 Creative Biolabs Competitive Strengths & Weaknesses
9.6 Twist Bioscience
9.6.1 Twist Bioscience Details
9.6.2 Twist Bioscience Major Business
9.6.3 Twist Bioscience Therapeutic Antibody Discovery Services Product and Services
9.6.4 Twist Bioscience Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Twist Bioscience Recent Developments/Updates
9.6.6 Twist Bioscience Competitive Strengths & Weaknesses
9.7 Rapid Novor
9.7.1 Rapid Novor Details
9.7.2 Rapid Novor Major Business
9.7.3 Rapid Novor Therapeutic Antibody Discovery Services Product and Services
9.7.4 Rapid Novor Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Rapid Novor Recent Developments/Updates
9.7.6 Rapid Novor Competitive Strengths & Weaknesses
9.8 Curia
9.8.1 Curia Details
9.8.2 Curia Major Business
9.8.3 Curia Therapeutic Antibody Discovery Services Product and Services
9.8.4 Curia Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Curia Recent Developments/Updates
9.8.6 Curia Competitive Strengths & Weaknesses
9.9 AlivaMab Biologics
9.9.1 AlivaMab Biologics Details
9.9.2 AlivaMab Biologics Major Business
9.9.3 AlivaMab Biologics Therapeutic Antibody Discovery Services Product and Services
9.9.4 AlivaMab Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 AlivaMab Biologics Recent Developments/Updates
9.9.6 AlivaMab Biologics Competitive Strengths & Weaknesses
9.10 Integrated DNA Technologies
9.10.1 Integrated DNA Technologies Details
9.10.2 Integrated DNA Technologies Major Business
9.10.3 Integrated DNA Technologies Therapeutic Antibody Discovery Services Product and Services
9.10.4 Integrated DNA Technologies Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Integrated DNA Technologies Recent Developments/Updates
9.10.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
9.11 Antibody Solutions
9.11.1 Antibody Solutions Details
9.11.2 Antibody Solutions Major Business
9.11.3 Antibody Solutions Therapeutic Antibody Discovery Services Product and Services
9.11.4 Antibody Solutions Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Antibody Solutions Recent Developments/Updates
9.11.6 Antibody Solutions Competitive Strengths & Weaknesses
9.12 Eurofins Discovery
9.12.1 Eurofins Discovery Details
9.12.2 Eurofins Discovery Major Business
9.12.3 Eurofins Discovery Therapeutic Antibody Discovery Services Product and Services
9.12.4 Eurofins Discovery Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Eurofins Discovery Recent Developments/Updates
9.12.6 Eurofins Discovery Competitive Strengths & Weaknesses
9.13 GenScript
9.13.1 GenScript Details
9.13.2 GenScript Major Business
9.13.3 GenScript Therapeutic Antibody Discovery Services Product and Services
9.13.4 GenScript Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 GenScript Recent Developments/Updates
9.13.6 GenScript Competitive Strengths & Weaknesses
9.14 Evotec
9.14.1 Evotec Details
9.14.2 Evotec Major Business
9.14.3 Evotec Therapeutic Antibody Discovery Services Product and Services
9.14.4 Evotec Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Evotec Recent Developments/Updates
9.14.6 Evotec Competitive Strengths & Weaknesses
9.15 Aurigene Pharmaceutical Services
9.15.1 Aurigene Pharmaceutical Services Details
9.15.2 Aurigene Pharmaceutical Services Major Business
9.15.3 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Product and Services
9.15.4 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Aurigene Pharmaceutical Services Recent Developments/Updates
9.15.6 Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
9.16 Yumab
9.16.1 Yumab Details
9.16.2 Yumab Major Business
9.16.3 Yumab Therapeutic Antibody Discovery Services Product and Services
9.16.4 Yumab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Yumab Recent Developments/Updates
9.16.6 Yumab Competitive Strengths & Weaknesses
9.17 Creative Bioarray
9.17.1 Creative Bioarray Details
9.17.2 Creative Bioarray Major Business
9.17.3 Creative Bioarray Therapeutic Antibody Discovery Services Product and Services
9.17.4 Creative Bioarray Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Creative Bioarray Recent Developments/Updates
9.17.6 Creative Bioarray Competitive Strengths & Weaknesses
9.18 CD ComputaBio
9.18.1 CD ComputaBio Details
9.18.2 CD ComputaBio Major Business
9.18.3 CD ComputaBio Therapeutic Antibody Discovery Services Product and Services
9.18.4 CD ComputaBio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 CD ComputaBio Recent Developments/Updates
9.18.6 CD ComputaBio Competitive Strengths & Weaknesses
9.19 Biomolecular Discovery Services
9.19.1 Biomolecular Discovery Services Details
9.19.2 Biomolecular Discovery Services Major Business
9.19.3 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Product and Services
9.19.4 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Biomolecular Discovery Services Recent Developments/Updates
9.19.6 Biomolecular Discovery Services Competitive Strengths & Weaknesses
9.20 ProteoGenix
9.20.1 ProteoGenix Details
9.20.2 ProteoGenix Major Business
9.20.3 ProteoGenix Therapeutic Antibody Discovery Services Product and Services
9.20.4 ProteoGenix Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 ProteoGenix Recent Developments/Updates
9.20.6 ProteoGenix Competitive Strengths & Weaknesses
9.21 Sichuan NB Biolab
9.21.1 Sichuan NB Biolab Details
9.21.2 Sichuan NB Biolab Major Business
9.21.3 Sichuan NB Biolab Therapeutic Antibody Discovery Services Product and Services
9.21.4 Sichuan NB Biolab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Sichuan NB Biolab Recent Developments/Updates
9.21.6 Sichuan NB Biolab Competitive Strengths & Weaknesses
9.22 Viva Biotech
9.22.1 Viva Biotech Details
9.22.2 Viva Biotech Major Business
9.22.3 Viva Biotech Therapeutic Antibody Discovery Services Product and Services
9.22.4 Viva Biotech Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Viva Biotech Recent Developments/Updates
9.22.6 Viva Biotech Competitive Strengths & Weaknesses
9.23 SAFE Pharmaceutical Technology
9.23.1 SAFE Pharmaceutical Technology Details
9.23.2 SAFE Pharmaceutical Technology Major Business
9.23.3 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Product and Services
9.23.4 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 SAFE Pharmaceutical Technology Recent Developments/Updates
9.23.6 SAFE Pharmaceutical Technology Competitive Strengths & Weaknesses
9.24 Shanghai Medicilon
9.24.1 Shanghai Medicilon Details
9.24.2 Shanghai Medicilon Major Business
9.24.3 Shanghai Medicilon Therapeutic Antibody Discovery Services Product and Services
9.24.4 Shanghai Medicilon Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Shanghai Medicilon Recent Developments/Updates
9.24.6 Shanghai Medicilon Competitive Strengths & Weaknesses
9.25 WuXi Biologics
9.25.1 WuXi Biologics Details
9.25.2 WuXi Biologics Major Business
9.25.3 WuXi Biologics Therapeutic Antibody Discovery Services Product and Services
9.25.4 WuXi Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 WuXi Biologics Recent Developments/Updates
9.25.6 WuXi Biologics Competitive Strengths & Weaknesses
9.26 XtalPi
9.26.1 XtalPi Details
9.26.2 XtalPi Major Business
9.26.3 XtalPi Therapeutic Antibody Discovery Services Product and Services
9.26.4 XtalPi Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 XtalPi Recent Developments/Updates
9.26.6 XtalPi Competitive Strengths & Weaknesses
9.27 Detaibio
9.27.1 Detaibio Details
9.27.2 Detaibio Major Business
9.27.3 Detaibio Therapeutic Antibody Discovery Services Product and Services
9.27.4 Detaibio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Detaibio Recent Developments/Updates
9.27.6 Detaibio Competitive Strengths & Weaknesses
9.28 Cusabio
9.28.1 Cusabio Details
9.28.2 Cusabio Major Business
9.28.3 Cusabio Therapeutic Antibody Discovery Services Product and Services
9.28.4 Cusabio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Cusabio Recent Developments/Updates
9.28.6 Cusabio Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Therapeutic Antibody Discovery Services Industry Chain
10.2 Therapeutic Antibody Discovery Services Upstream Analysis
10.3 Therapeutic Antibody Discovery Services Midstream Analysis
10.4 Therapeutic Antibody Discovery Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Therapeutic Antibody Discovery Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Therapeutic Antibody Discovery Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Therapeutic Antibody Discovery Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Therapeutic Antibody Discovery Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Therapeutic Antibody Discovery Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Therapeutic Antibody Discovery Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Therapeutic Antibody Discovery Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Therapeutic Antibody Discovery Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Therapeutic Antibody Discovery Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Therapeutic Antibody Discovery Services Players in 2025
Table 12. World Therapeutic Antibody Discovery Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Therapeutic Antibody Discovery Services Company Evaluation Quadrant
Table 14. Head Office of Key Therapeutic Antibody Discovery Services Players
Table 15. Therapeutic Antibody Discovery Services Market: Company Product Type Footprint
Table 16. Therapeutic Antibody Discovery Services Market: Company Product Application Footprint
Table 17. Therapeutic Antibody Discovery Services Mergers & Acquisitions Activity
Table 18. United States VS China Therapeutic Antibody Discovery Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Therapeutic Antibody Discovery Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Therapeutic Antibody Discovery Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Therapeutic Antibody Discovery Services Revenue Market Share (2021-2026)
Table 23. China Based Therapeutic Antibody Discovery Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Therapeutic Antibody Discovery Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Therapeutic Antibody Discovery Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Therapeutic Antibody Discovery Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Therapeutic Antibody Discovery Services Revenue Market Share (2021-2026)
Table 29. World Therapeutic Antibody Discovery Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Therapeutic Antibody Discovery Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Therapeutic Antibody Discovery Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Therapeutic Antibody Discovery Services Market Size by Antibody Sources, (USD Million), 2021 & 2025 & 2032
Table 33. World Therapeutic Antibody Discovery Services Market Size Value by Antibody Sources (2021-2026) & (USD Million)
Table 34. World Therapeutic Antibody Discovery Services Market Size by Antibody Sources (2027-2032) & (USD Million)
Table 35. World Therapeutic Antibody Discovery Services Market Size by Target Types, (USD Million), 2021 & 2025 & 2032
Table 36. World Therapeutic Antibody Discovery Services Market Size Value by Target Types (2021-2026) & (USD Million)
Table 37. World Therapeutic Antibody Discovery Services Market Size by Target Types (2027-2032) & (USD Million)
Table 38. World Therapeutic Antibody Discovery Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Therapeutic Antibody Discovery Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Biocytogen Basic Information, Manufacturing Base and Competitors
Table 42. Biocytogen Major Business
Table 43. Biocytogen Therapeutic Antibody Discovery Services Product and Services
Table 44. Biocytogen Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Biocytogen Recent Developments/Updates
Table 46. Biocytogen Competitive Strengths & Weaknesses
Table 47. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. Charles River Laboratories Major Business
Table 49. Charles River Laboratories Therapeutic Antibody Discovery Services Product and Services
Table 50. Charles River Laboratories Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Charles River Laboratories Recent Developments/Updates
Table 52. Charles River Laboratories Competitive Strengths & Weaknesses
Table 53. Abcam Basic Information, Manufacturing Base and Competitors
Table 54. Abcam Major Business
Table 55. Abcam Therapeutic Antibody Discovery Services Product and Services
Table 56. Abcam Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abcam Recent Developments/Updates
Table 58. Abcam Competitive Strengths & Weaknesses
Table 59. Alloy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. Alloy Therapeutics Major Business
Table 61. Alloy Therapeutics Therapeutic Antibody Discovery Services Product and Services
Table 62. Alloy Therapeutics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Alloy Therapeutics Recent Developments/Updates
Table 64. Alloy Therapeutics Competitive Strengths & Weaknesses
Table 65. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 66. Creative Biolabs Major Business
Table 67. Creative Biolabs Therapeutic Antibody Discovery Services Product and Services
Table 68. Creative Biolabs Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Creative Biolabs Recent Developments/Updates
Table 70. Creative Biolabs Competitive Strengths & Weaknesses
Table 71. Twist Bioscience Basic Information, Manufacturing Base and Competitors
Table 72. Twist Bioscience Major Business
Table 73. Twist Bioscience Therapeutic Antibody Discovery Services Product and Services
Table 74. Twist Bioscience Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Twist Bioscience Recent Developments/Updates
Table 76. Twist Bioscience Competitive Strengths & Weaknesses
Table 77. Rapid Novor Basic Information, Manufacturing Base and Competitors
Table 78. Rapid Novor Major Business
Table 79. Rapid Novor Therapeutic Antibody Discovery Services Product and Services
Table 80. Rapid Novor Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Rapid Novor Recent Developments/Updates
Table 82. Rapid Novor Competitive Strengths & Weaknesses
Table 83. Curia Basic Information, Manufacturing Base and Competitors
Table 84. Curia Major Business
Table 85. Curia Therapeutic Antibody Discovery Services Product and Services
Table 86. Curia Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Curia Recent Developments/Updates
Table 88. Curia Competitive Strengths & Weaknesses
Table 89. AlivaMab Biologics Basic Information, Manufacturing Base and Competitors
Table 90. AlivaMab Biologics Major Business
Table 91. AlivaMab Biologics Therapeutic Antibody Discovery Services Product and Services
Table 92. AlivaMab Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. AlivaMab Biologics Recent Developments/Updates
Table 94. AlivaMab Biologics Competitive Strengths & Weaknesses
Table 95. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors
Table 96. Integrated DNA Technologies Major Business
Table 97. Integrated DNA Technologies Therapeutic Antibody Discovery Services Product and Services
Table 98. Integrated DNA Technologies Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Integrated DNA Technologies Recent Developments/Updates
Table 100. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 101. Antibody Solutions Basic Information, Manufacturing Base and Competitors
Table 102. Antibody Solutions Major Business
Table 103. Antibody Solutions Therapeutic Antibody Discovery Services Product and Services
Table 104. Antibody Solutions Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Antibody Solutions Recent Developments/Updates
Table 106. Antibody Solutions Competitive Strengths & Weaknesses
Table 107. Eurofins Discovery Basic Information, Manufacturing Base and Competitors
Table 108. Eurofins Discovery Major Business
Table 109. Eurofins Discovery Therapeutic Antibody Discovery Services Product and Services
Table 110. Eurofins Discovery Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Eurofins Discovery Recent Developments/Updates
Table 112. Eurofins Discovery Competitive Strengths & Weaknesses
Table 113. GenScript Basic Information, Manufacturing Base and Competitors
Table 114. GenScript Major Business
Table 115. GenScript Therapeutic Antibody Discovery Services Product and Services
Table 116. GenScript Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. GenScript Recent Developments/Updates
Table 118. GenScript Competitive Strengths & Weaknesses
Table 119. Evotec Basic Information, Manufacturing Base and Competitors
Table 120. Evotec Major Business
Table 121. Evotec Therapeutic Antibody Discovery Services Product and Services
Table 122. Evotec Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Evotec Recent Developments/Updates
Table 124. Evotec Competitive Strengths & Weaknesses
Table 125. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 126. Aurigene Pharmaceutical Services Major Business
Table 127. Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Product and Services
Table 128. Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 130. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 131. Yumab Basic Information, Manufacturing Base and Competitors
Table 132. Yumab Major Business
Table 133. Yumab Therapeutic Antibody Discovery Services Product and Services
Table 134. Yumab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Yumab Recent Developments/Updates
Table 136. Yumab Competitive Strengths & Weaknesses
Table 137. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 138. Creative Bioarray Major Business
Table 139. Creative Bioarray Therapeutic Antibody Discovery Services Product and Services
Table 140. Creative Bioarray Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Creative Bioarray Recent Developments/Updates
Table 142. Creative Bioarray Competitive Strengths & Weaknesses
Table 143. CD ComputaBio Basic Information, Manufacturing Base and Competitors
Table 144. CD ComputaBio Major Business
Table 145. CD ComputaBio Therapeutic Antibody Discovery Services Product and Services
Table 146. CD ComputaBio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. CD ComputaBio Recent Developments/Updates
Table 148. CD ComputaBio Competitive Strengths & Weaknesses
Table 149. Biomolecular Discovery Services Basic Information, Manufacturing Base and Competitors
Table 150. Biomolecular Discovery Services Major Business
Table 151. Biomolecular Discovery Services Therapeutic Antibody Discovery Services Product and Services
Table 152. Biomolecular Discovery Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Biomolecular Discovery Services Recent Developments/Updates
Table 154. Biomolecular Discovery Services Competitive Strengths & Weaknesses
Table 155. ProteoGenix Basic Information, Manufacturing Base and Competitors
Table 156. ProteoGenix Major Business
Table 157. ProteoGenix Therapeutic Antibody Discovery Services Product and Services
Table 158. ProteoGenix Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. ProteoGenix Recent Developments/Updates
Table 160. ProteoGenix Competitive Strengths & Weaknesses
Table 161. Sichuan NB Biolab Basic Information, Manufacturing Base and Competitors
Table 162. Sichuan NB Biolab Major Business
Table 163. Sichuan NB Biolab Therapeutic Antibody Discovery Services Product and Services
Table 164. Sichuan NB Biolab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Sichuan NB Biolab Recent Developments/Updates
Table 166. Sichuan NB Biolab Competitive Strengths & Weaknesses
Table 167. Viva Biotech Basic Information, Manufacturing Base and Competitors
Table 168. Viva Biotech Major Business
Table 169. Viva Biotech Therapeutic Antibody Discovery Services Product and Services
Table 170. Viva Biotech Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Viva Biotech Recent Developments/Updates
Table 172. Viva Biotech Competitive Strengths & Weaknesses
Table 173. SAFE Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 174. SAFE Pharmaceutical Technology Major Business
Table 175. SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Product and Services
Table 176. SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. SAFE Pharmaceutical Technology Recent Developments/Updates
Table 178. SAFE Pharmaceutical Technology Competitive Strengths & Weaknesses
Table 179. Shanghai Medicilon Basic Information, Manufacturing Base and Competitors
Table 180. Shanghai Medicilon Major Business
Table 181. Shanghai Medicilon Therapeutic Antibody Discovery Services Product and Services
Table 182. Shanghai Medicilon Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Shanghai Medicilon Recent Developments/Updates
Table 184. Shanghai Medicilon Competitive Strengths & Weaknesses
Table 185. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 186. WuXi Biologics Major Business
Table 187. WuXi Biologics Therapeutic Antibody Discovery Services Product and Services
Table 188. WuXi Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. WuXi Biologics Recent Developments/Updates
Table 190. WuXi Biologics Competitive Strengths & Weaknesses
Table 191. XtalPi Basic Information, Manufacturing Base and Competitors
Table 192. XtalPi Major Business
Table 193. XtalPi Therapeutic Antibody Discovery Services Product and Services
Table 194. XtalPi Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. XtalPi Recent Developments/Updates
Table 196. XtalPi Competitive Strengths & Weaknesses
Table 197. Detaibio Basic Information, Manufacturing Base and Competitors
Table 198. Detaibio Major Business
Table 199. Detaibio Therapeutic Antibody Discovery Services Product and Services
Table 200. Detaibio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Detaibio Recent Developments/Updates
Table 202. Detaibio Competitive Strengths & Weaknesses
Table 203. Cusabio Basic Information, Manufacturing Base and Competitors
Table 204. Cusabio Major Business
Table 205. Cusabio Therapeutic Antibody Discovery Services Product and Services
Table 206. Cusabio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Cusabio Recent Developments/Updates
Table 208. Cusabio Competitive Strengths & Weaknesses
Table 209. Global Key Players of Therapeutic Antibody Discovery Services Upstream (Raw Materials)
Table 210. Global Therapeutic Antibody Discovery Services Typical Customers
Table 1. World Therapeutic Antibody Discovery Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Therapeutic Antibody Discovery Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Therapeutic Antibody Discovery Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Therapeutic Antibody Discovery Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Therapeutic Antibody Discovery Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Therapeutic Antibody Discovery Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Therapeutic Antibody Discovery Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Therapeutic Antibody Discovery Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Therapeutic Antibody Discovery Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Therapeutic Antibody Discovery Services Players in 2025
Table 12. World Therapeutic Antibody Discovery Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Therapeutic Antibody Discovery Services Company Evaluation Quadrant
Table 14. Head Office of Key Therapeutic Antibody Discovery Services Players
Table 15. Therapeutic Antibody Discovery Services Market: Company Product Type Footprint
Table 16. Therapeutic Antibody Discovery Services Market: Company Product Application Footprint
Table 17. Therapeutic Antibody Discovery Services Mergers & Acquisitions Activity
Table 18. United States VS China Therapeutic Antibody Discovery Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Therapeutic Antibody Discovery Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Therapeutic Antibody Discovery Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Therapeutic Antibody Discovery Services Revenue Market Share (2021-2026)
Table 23. China Based Therapeutic Antibody Discovery Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Therapeutic Antibody Discovery Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Therapeutic Antibody Discovery Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Therapeutic Antibody Discovery Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Therapeutic Antibody Discovery Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Therapeutic Antibody Discovery Services Revenue Market Share (2021-2026)
Table 29. World Therapeutic Antibody Discovery Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Therapeutic Antibody Discovery Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Therapeutic Antibody Discovery Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Therapeutic Antibody Discovery Services Market Size by Antibody Sources, (USD Million), 2021 & 2025 & 2032
Table 33. World Therapeutic Antibody Discovery Services Market Size Value by Antibody Sources (2021-2026) & (USD Million)
Table 34. World Therapeutic Antibody Discovery Services Market Size by Antibody Sources (2027-2032) & (USD Million)
Table 35. World Therapeutic Antibody Discovery Services Market Size by Target Types, (USD Million), 2021 & 2025 & 2032
Table 36. World Therapeutic Antibody Discovery Services Market Size Value by Target Types (2021-2026) & (USD Million)
Table 37. World Therapeutic Antibody Discovery Services Market Size by Target Types (2027-2032) & (USD Million)
Table 38. World Therapeutic Antibody Discovery Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Therapeutic Antibody Discovery Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Therapeutic Antibody Discovery Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Biocytogen Basic Information, Manufacturing Base and Competitors
Table 42. Biocytogen Major Business
Table 43. Biocytogen Therapeutic Antibody Discovery Services Product and Services
Table 44. Biocytogen Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Biocytogen Recent Developments/Updates
Table 46. Biocytogen Competitive Strengths & Weaknesses
Table 47. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. Charles River Laboratories Major Business
Table 49. Charles River Laboratories Therapeutic Antibody Discovery Services Product and Services
Table 50. Charles River Laboratories Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Charles River Laboratories Recent Developments/Updates
Table 52. Charles River Laboratories Competitive Strengths & Weaknesses
Table 53. Abcam Basic Information, Manufacturing Base and Competitors
Table 54. Abcam Major Business
Table 55. Abcam Therapeutic Antibody Discovery Services Product and Services
Table 56. Abcam Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abcam Recent Developments/Updates
Table 58. Abcam Competitive Strengths & Weaknesses
Table 59. Alloy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 60. Alloy Therapeutics Major Business
Table 61. Alloy Therapeutics Therapeutic Antibody Discovery Services Product and Services
Table 62. Alloy Therapeutics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Alloy Therapeutics Recent Developments/Updates
Table 64. Alloy Therapeutics Competitive Strengths & Weaknesses
Table 65. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 66. Creative Biolabs Major Business
Table 67. Creative Biolabs Therapeutic Antibody Discovery Services Product and Services
Table 68. Creative Biolabs Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Creative Biolabs Recent Developments/Updates
Table 70. Creative Biolabs Competitive Strengths & Weaknesses
Table 71. Twist Bioscience Basic Information, Manufacturing Base and Competitors
Table 72. Twist Bioscience Major Business
Table 73. Twist Bioscience Therapeutic Antibody Discovery Services Product and Services
Table 74. Twist Bioscience Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Twist Bioscience Recent Developments/Updates
Table 76. Twist Bioscience Competitive Strengths & Weaknesses
Table 77. Rapid Novor Basic Information, Manufacturing Base and Competitors
Table 78. Rapid Novor Major Business
Table 79. Rapid Novor Therapeutic Antibody Discovery Services Product and Services
Table 80. Rapid Novor Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Rapid Novor Recent Developments/Updates
Table 82. Rapid Novor Competitive Strengths & Weaknesses
Table 83. Curia Basic Information, Manufacturing Base and Competitors
Table 84. Curia Major Business
Table 85. Curia Therapeutic Antibody Discovery Services Product and Services
Table 86. Curia Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Curia Recent Developments/Updates
Table 88. Curia Competitive Strengths & Weaknesses
Table 89. AlivaMab Biologics Basic Information, Manufacturing Base and Competitors
Table 90. AlivaMab Biologics Major Business
Table 91. AlivaMab Biologics Therapeutic Antibody Discovery Services Product and Services
Table 92. AlivaMab Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. AlivaMab Biologics Recent Developments/Updates
Table 94. AlivaMab Biologics Competitive Strengths & Weaknesses
Table 95. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors
Table 96. Integrated DNA Technologies Major Business
Table 97. Integrated DNA Technologies Therapeutic Antibody Discovery Services Product and Services
Table 98. Integrated DNA Technologies Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Integrated DNA Technologies Recent Developments/Updates
Table 100. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 101. Antibody Solutions Basic Information, Manufacturing Base and Competitors
Table 102. Antibody Solutions Major Business
Table 103. Antibody Solutions Therapeutic Antibody Discovery Services Product and Services
Table 104. Antibody Solutions Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Antibody Solutions Recent Developments/Updates
Table 106. Antibody Solutions Competitive Strengths & Weaknesses
Table 107. Eurofins Discovery Basic Information, Manufacturing Base and Competitors
Table 108. Eurofins Discovery Major Business
Table 109. Eurofins Discovery Therapeutic Antibody Discovery Services Product and Services
Table 110. Eurofins Discovery Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Eurofins Discovery Recent Developments/Updates
Table 112. Eurofins Discovery Competitive Strengths & Weaknesses
Table 113. GenScript Basic Information, Manufacturing Base and Competitors
Table 114. GenScript Major Business
Table 115. GenScript Therapeutic Antibody Discovery Services Product and Services
Table 116. GenScript Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. GenScript Recent Developments/Updates
Table 118. GenScript Competitive Strengths & Weaknesses
Table 119. Evotec Basic Information, Manufacturing Base and Competitors
Table 120. Evotec Major Business
Table 121. Evotec Therapeutic Antibody Discovery Services Product and Services
Table 122. Evotec Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Evotec Recent Developments/Updates
Table 124. Evotec Competitive Strengths & Weaknesses
Table 125. Aurigene Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 126. Aurigene Pharmaceutical Services Major Business
Table 127. Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Product and Services
Table 128. Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Aurigene Pharmaceutical Services Recent Developments/Updates
Table 130. Aurigene Pharmaceutical Services Competitive Strengths & Weaknesses
Table 131. Yumab Basic Information, Manufacturing Base and Competitors
Table 132. Yumab Major Business
Table 133. Yumab Therapeutic Antibody Discovery Services Product and Services
Table 134. Yumab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Yumab Recent Developments/Updates
Table 136. Yumab Competitive Strengths & Weaknesses
Table 137. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 138. Creative Bioarray Major Business
Table 139. Creative Bioarray Therapeutic Antibody Discovery Services Product and Services
Table 140. Creative Bioarray Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Creative Bioarray Recent Developments/Updates
Table 142. Creative Bioarray Competitive Strengths & Weaknesses
Table 143. CD ComputaBio Basic Information, Manufacturing Base and Competitors
Table 144. CD ComputaBio Major Business
Table 145. CD ComputaBio Therapeutic Antibody Discovery Services Product and Services
Table 146. CD ComputaBio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. CD ComputaBio Recent Developments/Updates
Table 148. CD ComputaBio Competitive Strengths & Weaknesses
Table 149. Biomolecular Discovery Services Basic Information, Manufacturing Base and Competitors
Table 150. Biomolecular Discovery Services Major Business
Table 151. Biomolecular Discovery Services Therapeutic Antibody Discovery Services Product and Services
Table 152. Biomolecular Discovery Services Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Biomolecular Discovery Services Recent Developments/Updates
Table 154. Biomolecular Discovery Services Competitive Strengths & Weaknesses
Table 155. ProteoGenix Basic Information, Manufacturing Base and Competitors
Table 156. ProteoGenix Major Business
Table 157. ProteoGenix Therapeutic Antibody Discovery Services Product and Services
Table 158. ProteoGenix Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. ProteoGenix Recent Developments/Updates
Table 160. ProteoGenix Competitive Strengths & Weaknesses
Table 161. Sichuan NB Biolab Basic Information, Manufacturing Base and Competitors
Table 162. Sichuan NB Biolab Major Business
Table 163. Sichuan NB Biolab Therapeutic Antibody Discovery Services Product and Services
Table 164. Sichuan NB Biolab Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Sichuan NB Biolab Recent Developments/Updates
Table 166. Sichuan NB Biolab Competitive Strengths & Weaknesses
Table 167. Viva Biotech Basic Information, Manufacturing Base and Competitors
Table 168. Viva Biotech Major Business
Table 169. Viva Biotech Therapeutic Antibody Discovery Services Product and Services
Table 170. Viva Biotech Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Viva Biotech Recent Developments/Updates
Table 172. Viva Biotech Competitive Strengths & Weaknesses
Table 173. SAFE Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 174. SAFE Pharmaceutical Technology Major Business
Table 175. SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Product and Services
Table 176. SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. SAFE Pharmaceutical Technology Recent Developments/Updates
Table 178. SAFE Pharmaceutical Technology Competitive Strengths & Weaknesses
Table 179. Shanghai Medicilon Basic Information, Manufacturing Base and Competitors
Table 180. Shanghai Medicilon Major Business
Table 181. Shanghai Medicilon Therapeutic Antibody Discovery Services Product and Services
Table 182. Shanghai Medicilon Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Shanghai Medicilon Recent Developments/Updates
Table 184. Shanghai Medicilon Competitive Strengths & Weaknesses
Table 185. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 186. WuXi Biologics Major Business
Table 187. WuXi Biologics Therapeutic Antibody Discovery Services Product and Services
Table 188. WuXi Biologics Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. WuXi Biologics Recent Developments/Updates
Table 190. WuXi Biologics Competitive Strengths & Weaknesses
Table 191. XtalPi Basic Information, Manufacturing Base and Competitors
Table 192. XtalPi Major Business
Table 193. XtalPi Therapeutic Antibody Discovery Services Product and Services
Table 194. XtalPi Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. XtalPi Recent Developments/Updates
Table 196. XtalPi Competitive Strengths & Weaknesses
Table 197. Detaibio Basic Information, Manufacturing Base and Competitors
Table 198. Detaibio Major Business
Table 199. Detaibio Therapeutic Antibody Discovery Services Product and Services
Table 200. Detaibio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Detaibio Recent Developments/Updates
Table 202. Detaibio Competitive Strengths & Weaknesses
Table 203. Cusabio Basic Information, Manufacturing Base and Competitors
Table 204. Cusabio Major Business
Table 205. Cusabio Therapeutic Antibody Discovery Services Product and Services
Table 206. Cusabio Therapeutic Antibody Discovery Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Cusabio Recent Developments/Updates
Table 208. Cusabio Competitive Strengths & Weaknesses
Table 209. Global Key Players of Therapeutic Antibody Discovery Services Upstream (Raw Materials)
Table 210. Global Therapeutic Antibody Discovery Services Typical Customers
LIST OF FIGURES
Figure 1. Therapeutic Antibody Discovery Services Picture
Figure 2. World Therapeutic Antibody Discovery Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Therapeutic Antibody Discovery Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Therapeutic Antibody Discovery Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Therapeutic Antibody Discovery Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 13. Therapeutic Antibody Discovery Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Therapeutic Antibody Discovery Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Therapeutic Antibody Discovery Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Therapeutic Antibody Discovery Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Therapeutic Antibody Discovery Services Markets in 2025
Figure 27. United States VS China: Therapeutic Antibody Discovery Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Therapeutic Antibody Discovery Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Therapeutic Antibody Discovery Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Therapeutic Antibody Discovery Services Market Size Market Share by Type in 2025
Figure 31. Discovery of CAR-T Antibody Drugs
Figure 32. Discovery of Monoclonal Antibody Drugs
Figure 33. Discovery of ADC Antibody Drugs
Figure 34. Others
Figure 35. World Therapeutic Antibody Discovery Services Market Size Market Share by Type (2021-2032)
Figure 36. World Therapeutic Antibody Discovery Services Market Size by Antibody Sources, (USD Million), 2021 & 2025 & 2032
Figure 37. World Therapeutic Antibody Discovery Services Market Size Market Share by Antibody Sources in 2025
Figure 38. Mouse Antibodies
Figure 39. Chimeric Antibodies
Figure 40. Humanized Antibodies
Figure 41. Fully Human Antibodies
Figure 42. World Therapeutic Antibody Discovery Services Market Size Market Share by Antibody Sources (2021-2032)
Figure 43. World Therapeutic Antibody Discovery Services Market Size by Target Types, (USD Million), 2021 & 2025 & 2032
Figure 44. World Therapeutic Antibody Discovery Services Market Size Market Share by Target Types in 2025
Figure 45. Soluble Protein Targets
Figure 46. Membrane Protein Targets
Figure 47. GPCR Targets
Figure 48. Ion Channel Targets
Figure 49. Cell Surface Antigen Targets
Figure 50. World Therapeutic Antibody Discovery Services Market Size Market Share by Target Types (2021-2032)
Figure 51. World Therapeutic Antibody Discovery Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Therapeutic Antibody Discovery Services Market Size Market Share by Application in 2025
Figure 53. Biotechnology
Figure 54. Medical
Figure 55. University
Figure 56. Others
Figure 57. World Therapeutic Antibody Discovery Services Market Size Market Share by Application (2021-2032)
Figure 58. Therapeutic Antibody Discovery Services Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. Therapeutic Antibody Discovery Services Picture
Figure 2. World Therapeutic Antibody Discovery Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Therapeutic Antibody Discovery Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Therapeutic Antibody Discovery Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Therapeutic Antibody Discovery Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Therapeutic Antibody Discovery Services Revenue (2021-2032) & (USD Million)
Figure 13. Therapeutic Antibody Discovery Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Therapeutic Antibody Discovery Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Therapeutic Antibody Discovery Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Therapeutic Antibody Discovery Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Therapeutic Antibody Discovery Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Therapeutic Antibody Discovery Services Markets in 2025
Figure 27. United States VS China: Therapeutic Antibody Discovery Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Therapeutic Antibody Discovery Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Therapeutic Antibody Discovery Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Therapeutic Antibody Discovery Services Market Size Market Share by Type in 2025
Figure 31. Discovery of CAR-T Antibody Drugs
Figure 32. Discovery of Monoclonal Antibody Drugs
Figure 33. Discovery of ADC Antibody Drugs
Figure 34. Others
Figure 35. World Therapeutic Antibody Discovery Services Market Size Market Share by Type (2021-2032)
Figure 36. World Therapeutic Antibody Discovery Services Market Size by Antibody Sources, (USD Million), 2021 & 2025 & 2032
Figure 37. World Therapeutic Antibody Discovery Services Market Size Market Share by Antibody Sources in 2025
Figure 38. Mouse Antibodies
Figure 39. Chimeric Antibodies
Figure 40. Humanized Antibodies
Figure 41. Fully Human Antibodies
Figure 42. World Therapeutic Antibody Discovery Services Market Size Market Share by Antibody Sources (2021-2032)
Figure 43. World Therapeutic Antibody Discovery Services Market Size by Target Types, (USD Million), 2021 & 2025 & 2032
Figure 44. World Therapeutic Antibody Discovery Services Market Size Market Share by Target Types in 2025
Figure 45. Soluble Protein Targets
Figure 46. Membrane Protein Targets
Figure 47. GPCR Targets
Figure 48. Ion Channel Targets
Figure 49. Cell Surface Antigen Targets
Figure 50. World Therapeutic Antibody Discovery Services Market Size Market Share by Target Types (2021-2032)
Figure 51. World Therapeutic Antibody Discovery Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Therapeutic Antibody Discovery Services Market Size Market Share by Application in 2025
Figure 53. Biotechnology
Figure 54. Medical
Figure 55. University
Figure 56. Others
Figure 57. World Therapeutic Antibody Discovery Services Market Size Market Share by Application (2021-2032)
Figure 58. Therapeutic Antibody Discovery Services Industrial Chain
Figure 59. Methodology
Figure 60. Research Process and Data Source
